Pulmonary Arterial Hypertension in a Patient With Hereditary Hemorrhagic Telangiectasia

[1]  Horst Olschewski,et al.  Updated clinical classification of pulmonary hypertension. , 2009, Journal of the American College of Cardiology.

[2]  J. Granton,et al.  The pulmonary vascular complications of hereditary haemorrhagic telangiectasia , 2009, European Respiratory Journal.

[3]  C. Shovlin,et al.  Embolisation of pulmonary arteriovenous malformations: no consistent effect on pulmonary artery pressure , 2008, European Respiratory Journal.

[4]  H. Popper,et al.  Early-life pulmonary arterial hypertension with subsequent development of diffuse pulmonary arteriovenous malformations in hereditary haemorrhagic telangiectasia type 1 , 2007, Thorax.

[5]  V. Cottin,et al.  Pulmonary Vascular Manifestations of Hereditary Hemorrhagic Telangiectasia (Rendu-Osler Disease) , 2007, Respiration.

[6]  A. Arroliga,et al.  Long-term outcome in a patient with pulmonary hypertension and hereditary hemorrhagic telangiectasia. , 2007, Chest.

[7]  J. Cogan,et al.  High frequency of BMPR2 exonic deletions/duplications in familial pulmonary arterial hypertension. , 2006, American journal of respiratory and critical care medicine.

[8]  D. Bonderman,et al.  Bosentan therapy for pulmonary arterial hypertension associated with hereditary haemorrhagic telangiectasia , 2006, European journal of clinical investigation.

[9]  R. Trembath,et al.  Molecular and functional analysis identifies ALK-1 as the predominant cause of pulmonary hypertension related to hereditary haemorrhagic telangiectasia , 2003, Journal of medical genetics.

[10]  A. Guttmacher,et al.  Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome). , 2000, American journal of medical genetics.

[11]  J. T. ten Berg,et al.  Unusual complications after embolization of a pulmonary arteriovenous malformation. , 1996, Chest.